RETRACTED: A Systematic Review of Lymphangioleiomyomatosis on Diagnosis and Molecular Mechanism (Retracted Article)

被引:5
作者
Dong, Xiaotong [1 ]
Jin, Lvcheng [1 ]
Wang, Ailan [2 ]
Wu, Liping [3 ]
Fan, Xintong [1 ]
Hou, Qian [1 ]
Li, Tianbao [2 ]
Zhao, Ruilian [4 ]
Zhang, Yunxiang [1 ]
机构
[1] Weifang Med Univ, Weifang Peoples Hosp, Dept Pathol, Affiliated Hosp 1, Weifang 261041, Peoples R China
[2] Qingdao Geneis Inst Big Data Min & Precis Med, Dept Sci, Qingdao, Peoples R China
[3] Weifang Med Univ, Weifang Peoples Hosp, Dept Resp, Affiliated Hosp 1, Weifang 261041, Peoples R China
[4] Weifang Med Univ, Dept Gen Practice, Affiliated Hosp, Weifang 261031, Peoples R China
关键词
D O I
10.1155/2021/6612776
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective. Lymphangioleiomyomatosis (LAM) is a rare low-grade metastatic tumor; however, LAM patients were always found in young age with difficulty for diagnosis. Our study is aimed at observing the clinical characteristics of patients with lymphangiomatosis, including the clinical manifestations, imaging findings, histopathological features, and immunophenotype. Methods. We did a systematic review on LAM/PLAM cases, especially on male cases, and collected the clinical features and molecular mechanisms of PLAM based on previous findings. Results. Diagnosis criteria were summarized by combining CT scans, MRI, immunohistochemistry results, and gene sequencing results for effectively distinguishing between PLAM and similar diseases. Moreover, our study illustrated the molecular mechanism of PLAM as well as the signaling pathway involved in the disease initials. In addition, a male case was reported with differential diagnosis on the clinical manifestations, microscopic features, immunophenotypes, and genotypes. Conclusion. Our review will definitely improve the understanding of diagnosis and treatment in PLAM cases.
引用
收藏
页数:8
相关论文
共 49 条
  • [1] Lymphangioleiomyomatosis: Abdominopelvic CT and US findings
    Avila, NA
    Kelly, JA
    Chu, SC
    Dwyer, AJ
    Moss, J
    [J]. RADIOLOGY, 2000, 216 (01) : 147 - 153
  • [2] Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
    Carsillo, T
    Astrinidis, A
    Henske, EP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) : 6085 - 6090
  • [3] Role of thoracic imaging in the management of lymphangioleiomyomatosis
    Crivelli, Paola
    Ledda, Roberta Eufrasia
    Terraneo, Silvia
    Conti, Maurizio
    Imeri, Gianluca
    Lesma, Elena
    Di Marco, Fabiano
    [J]. RESPIRATORY MEDICINE, 2019, 157 : 14 - 20
  • [4] TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1
    Dibble, Christian C.
    Elis, Winfried
    Menon, Suchithra
    Qin, Wei
    Klekota, Justin
    Asara, John M.
    Finan, Peter M.
    Kwiatkowski, David J.
    Murphy, Leon O.
    Manning, Brendan D.
    [J]. MOLECULAR CELL, 2012, 47 (04) : 535 - 546
  • [5] Tuberous Sclerosis Complex: Neurological, Renal and Pulmonary Manifestations
    Franz, D. N.
    Bissler, J. J.
    McCormack, F. X.
    [J]. NEUROPEDIATRICS, 2010, 41 (05) : 199 - 208
  • [6] mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
    Garcia-Martinez, Juan M.
    Alessi, Dario R.
    [J]. BIOCHEMICAL JOURNAL, 2008, 416 : 375 - 385
  • [7] mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells
    Goncharova, Elena A.
    Goncharov, Dmitry A.
    Li, Hua
    Pimtong, Wittaya
    Lu, Stephen
    Khavin, Irene
    Krymskaya, Vera P.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (12) : 2484 - 2498
  • [8] Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer
    Goodman, Merit L.
    Trinca, Gloria M.
    Walter, Katherine R.
    Papachristou, Evangelia K.
    D'Santos, Clive S.
    Li, Tianbao
    Liu, Qi
    Lai, Zhao
    Chalise, Prabhakar
    Madan, Rashna
    Fan, Fang
    Markiewicz, Mary A.
    Jin, Victor X.
    Carroll, Jason S.
    Hagan, Christy R.
    [J]. JOURNAL OF IMMUNOLOGY, 2019, 202 (10) : 3076 - 3086
  • [9] Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis
    Gu, Xiaoxiao
    Yu, Jane J.
    Ilter, Didem
    Blenis, Nickolas
    Henske, Elizabeth Petri
    Blenis, John
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (37) : 14960 - 14965
  • [10] Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis
    Harari, Sergio
    Spagnolo, Paolo
    Cocconcelli, Elisabetta
    Luisi, Francesca
    Cottin, Vincent
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (05) : 469 - 476